GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Poly Medicure Ltd (NSE:POLYMED) » Definitions » COGS-to-Revenue

Poly Medicure (NSE:POLYMED) COGS-to-Revenue : 0.35 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Poly Medicure COGS-to-Revenue?

Poly Medicure's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹1,312 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹3,781 Mil.

Poly Medicure's COGS to Revenue for the three months ended in Mar. 2024 was 0.35.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Poly Medicure's Gross Margin % for the three months ended in Mar. 2024 was 65.30%.


Poly Medicure COGS-to-Revenue Historical Data

The historical data trend for Poly Medicure's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poly Medicure COGS-to-Revenue Chart

Poly Medicure Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.43 0.47 0.36 0.35

Poly Medicure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.35 0.36 0.35 0.35

Poly Medicure COGS-to-Revenue Calculation

Poly Medicure's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=4826.076 / 13757.963
=0.35

Poly Medicure's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1312.041 / 3780.742
=0.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poly Medicure  (NSE:POLYMED) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Poly Medicure's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 1312.041 / 3780.742
=65.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Poly Medicure COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Poly Medicure's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Poly Medicure (NSE:POLYMED) Business Description

Traded in Other Exchanges
Address
Okhla Industrial Estate, 232-B, 3rd Floor, Phase III, New Delhi, IND, 110020
Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Poly Medicure (NSE:POLYMED) Headlines

No Headlines